None listed
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: a. Able to give voluntary informed consent for collection of blood samples and relevant data for analysis and publication. b. Either gender, aged above 18 years.
Exclusion criteria
Exclusion criteria: a. Volunteers who are already on hydroxychloroquine prophylaxis and have less than 5 weeks remaining out of 8 weeks of hydroxychloroquine prophylaxis for COVID-19 infection. b. Volunteers who are already on hydroxychloroquine prophylaxis and develop any adverse drug reaction (ADR) to hydroxychloroquine leading to hospitalization or discontinuation at any time.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the peak and trough values achieved in blood over the course of the prophylactic drug administration.Timepoint: The estimated concentration for the sampling time points (hr) 0.00, 4.00, 168.00, 336.00, 340.00, 504.00, 672.00, 676.00, 840.00, 1008.00 and 1176.00 will be reported with descriptive statistical analysis. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hydroxychloroquine levels achieved in blood will be compared with literature values of EC 50.Timepoint: The estimated concentration for the sampling time points (hr) 0.00, 4.00, 168.00, 336.00, 340.00, 504.00, 672.00, 676.00, 840.00, 1008.00 and 1176.00 will be reported with descriptive statistical analysis. | — |
Countries
India
Contacts
Norwich Clinical Services Pvt. Ltd.